Both in Biotechnology
Solid Biosciences vs Prime Medicine
Over the past year SLDB returned +18.8% and PRME returned −0.1%; their daily moves had a correlation of 0.51.
SLDB +18.8% PRME −0.1%Growth of $1, one year, split-adjusted
| Metric | SLDB | PRME |
|---|---|---|
| Price | $6.18 | $4.56 |
| Market cap | $662.7M | $826.2M |
| Today | +3.00% | +2.59% |
| 1 month | −12.5% | +41.9% |
| 6 months | −10.4% | +34.4% |
| Year to date | +9.6% | +31.3% |
| 1 year | +14.7% | −7.8% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −3649.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 202.8× |
| Net cash | $377.7M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 67.9% | 111.7% |
| Short % of float | 17.8% | 34.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).